Sign inJoin waitlistJoin the waitlist

Stuart Seropian

Associate Program Director · Yale-New Haven Hospital

Credentials: · · ·

History

Yale-New Haven Hospital
Present
Immune Effector Cell Therapy · Yale-New Haven Hospital
Present
Adult CAR T-Cell Therapy Program · Yale-New Haven Hospital
Present

Yale-New Haven Hospital
1991–1992
Yale-New Haven Hospital
1991–1992
George Washington Univ Sch of Med
1987–1991
Tufts University
1980–1984
Tufts University
1981–1984

Research

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
The Lancet Haematology · 2021 · 305 citations
Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts
Journal of Clinical Investigation · 2015 · 228 citations
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes
Chest · 2020 · 163 citations

Dennis Cooper
27 papers
Francine Foss
18 papers
Iris Isufi
16 papers
Lohith Gowda
15 papers
Amer Zeidan
9 papers
Nikolai Podoltsev
7 papers · 2 as a resident
RS
Rory Shallis
6 papers
Scott Huntington
6 papers
Bouthaina Dabaja
5 papers
CM
Carolyn Mulroney
5 papers
Cecil Benitez
5 papers · 1 as a resident
CB
Celeste Bello
5 papers

Clinical trials

Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Principal investigator · Terminated · Phase 1, Phase 2
Yale University
2008–2013
Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
Principal investigator · Completed · Early phase 1
Yale University
2007–2014